Skip to main content

Advertisement

SpringerLink
Log in

Administering intravenous immunoglobulin during infection is associated with infusion reactions in selected patients

  • Original Article
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Background

Guidelines vary regarding the safety of administering intravenous immunoglobulin (IVIG) during infections, although evidence for this advice is lacking and is based on expert opinion.

Aims

We retrospectively studied patients with common variable immunodeficiency who reacted during IVIG therapy as to whether routinely obtained markers of infection such as C-reactive protein (CRP) were elevated.

Methods

19 patients on replacement IVIG therapy in a hospital-based infusion unit were studied. CRP levels obtained were normalized to baseline levels without reactions (defined as 100).

Results

8 of 19 patients had 16 reactions over a total of 107 infusions. Normalized CRP levels during reactions were higher [mean (±SD) of 258 (±215)] than during infusions with no reaction [mean 100 (±54.9), p = 0.017], and higher than in patients who did not react [mean 100 (±79.7), p = 0.017].

Conclusions

Some patients with IVIG reactions had elevated CRP levels suggesting that concurrent infection may have caused the reaction. Pre-emptive antibiotic therapy and delaying infusion could prevent unnecessary morbidity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. El-Shanawany T, Sewell WA, Misbah SA, Jolles S (2006) Current clinical uses of intravenous immunoglobulin. Clin Med 6(4):356–359

    CAS  PubMed  Google Scholar 

  2. Bonilla FA (2008) Intravenous immunoglobulin: adverse reactions and management. J Allergy Clin Immunol 122(6):1238–1239

    Article  PubMed  Google Scholar 

  3. UK-Primary Immunodeficiency Network (UKPIN) guideline 2.01. Administration of IVIG. http://www.ukpin.org.uk/guidelines5-01.html. Accessed 5 May 2009

  4. Brennan VM, Salomé-Bentley NJ, Chapel HM (2003) Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin. Clin Exp Immunol 133(2):247–251

    Article  CAS  PubMed  Google Scholar 

  5. Conley ME, Notarangelo LD, Etzioni A (1999) Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93(3):190–197

    Article  CAS  PubMed  Google Scholar 

  6. Orange JS, Hossny EM, Weiler CR et al (2006) Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma, Immunology. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma, Immunology. J Allergy Clin Immunol 117(4 Suppl):S525–S553

    Article  CAS  PubMed  Google Scholar 

  7. Day NK, Good RA, Wahn V (1984) Adverse reactions in selected patients following intravenous infusions of gamma globulin. Am J Med 76(3A):25–32

    Article  CAS  PubMed  Google Scholar 

  8. Wahn V (1984) Intravenous gamma globulin therapy. Measurement of circulating immune complexes and complement factors. Fortschr Med 102(31–32):795–798

    CAS  PubMed  Google Scholar 

  9. Lingard H, Zehetmayer S, Maier M (2008) Bacterial superinfection in upper respiratory tract infections estimated by increases in CRP values: a diagnostic follow-up in primary care. Scand J Prim Health Care 26(4):211–215

    Article  PubMed  Google Scholar 

  10. Melbye H, Hvidsten D, Holm A, Nordbø SA, Brox J (2004) The course of C-reactive protein response in untreated upper respiratory tract infection. Br J Gen Pract 54(506):653–658

    PubMed  Google Scholar 

  11. Pettit SJ, Bourne H, Spickett GP (2002) Survey of infection in patients receiving antibody replacement treatment for immune deficiency. J Clin Pathol 55(8):577–580

    Article  CAS  PubMed  Google Scholar 

  12. Rhodes B, Merriman ME, Harrison A et al (2010) A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation. PLoS Med 7(9):e1000341

    Article  PubMed  Google Scholar 

  13. Provan D, Chapel HM, Sewell WAC, O’Shaughnessy D (2008) Prescribing intravenous immunoglobulin: summary of Department of Health Guidelines. BMJ 337:990–992

    Article  Google Scholar 

Download references

Acknowledgments

We thank the nursing staff at Scunthorpe General Hospital and Hull Royal Infirmary for help with the data collection. WACS is Director of the Centre for Immunoglobulin Therapy, who has received unrestricted educational grants from Octapharma, Baxter, Grifols, CSL-Behring. There was no specific funding for this study.

Author information

Authors and Affiliations

  1. Department of Immunology, Frimley Park Hospital NHS Foundation Trust, Frimley, Camberley, Surrey, GU16 7UJ, UK

    S. Khan

  2. Centre for Immunoglobulin Therapy, Scunthorpe General Hospital, Scunthorpe, UK

    S. Khan & W. A. C. Sewell

  3. Department of Immunology, Hull Royal Infirmary, Hull, UK

    M. Abuzakouk & P. C. Doré

  4. Hull York Medical School, Hull, UK

    M. Abuzakouk, P. C. Doré & W. A. C. Sewell

Authors
  1. S. Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Abuzakouk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. C. Doré
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. A. C. Sewell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Khan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khan, S., Abuzakouk, M., Doré, P.C. et al. Administering intravenous immunoglobulin during infection is associated with infusion reactions in selected patients. Ir J Med Sci 180, 125–128 (2011). https://doi.org/10.1007/s11845-010-0654-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-010-0654-4

Keywords

Search

Navigation